Citation Impact
Citing Papers
Microsatellite Instability, Mismatch Repair Deficiency, and BRAF Mutation in Treatment-Resistant Germ Cell Tumors
2009
Cloning of a human parvovirus by molecular screening of respiratory tract samples
2005 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours – a retrospective long-term follow-up study
2003
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Testicular cancer and Hodgkin's disease: evaluation of semen quality
2003
EGFR Antagonists in Cancer Treatment
2008 Standout
Testicular Germ-Cell Cancer
1997 Standout
Parvovirus B19 infection infrequently involved in children and adults with myelodysplastic syndrome
1996
Antibodies to parvovirus B19 NS-1 protein in infected individuals
1995
A regional experience of red cell aplasia
1993
Pathogenesis of human parvovirus B19 in rheumatic disease
2000
Head and neck cancer
2008 Standout
Parvovirus B19 causing leucopenia and neutropenia in a healthy adult
2000
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
2 B19 parvovirus
1995
Late toxicity following curative treatment of testicular cancer
1999
Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy
2003
Cisplatin Nephrotoxicity: A Review
2007 Standout
Parvovirus B19 infection and autoimmune disease
2003
Testicular germ-cell tumours in a broader perspective
2005 Standout
Toxicity of platinum compounds
2003
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [18F]FDG PET
2002
Molecular, cellular and clinical aspects of Parvovirus B19 infection
1994
Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood
2003
Cisplatin: The first metal based anticancer drug
2019 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Antibodies to the Nonstructural Protein of Parvovirus B19 in Persistently Infected Patients: Implications for Pathogenesis
1995
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Parvovirus B19
2004 Standout
Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens
2004
Human Parvovirus B19
2002 Standout
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions
1993
Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
2006
Generation of Neutralizing Human Monoclonal Antibodies against Parvovirus B19 Proteins
1999
Postchemotherapy Retroperitoneal Surgery Remains Necessary in Patients With Nonseminomatous Testicular Cancer and Minimal Residual Tumor Masses
2003
Phase I/II Study of Cetuximab in Combination With Cisplatin or Carboplatin and Fluorouracil in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
2006
The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability
2001
Lymphoproliferative responses after infection with human parvovirus B19
1996
Works of Jörg Pont being referenced
Fertility after chemotherapy for testicular germ cell cancer
1997
Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection
1992
Usefulness of Chromogranin A as a Marker for Detection of Relapses of Carcinoid Tumours
1998
Docetaxel/cisplatin as first‐line chemotherapy in patients with head and neck carcinoma
2002
Second-Line Chemotherapy in Patients With Relapsed Extragonadal Nonseminomatous Germ Cell Tumors: Results of an International Multicenter Analysis
2001
Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis
2002
Predictive Impact of 2-18Fluoro-2-Deoxy-d -Glucose Positron Emission Tomography for Residual Postchemotherapy Masses in Patients With Bulky Seminoma
2001